BLQ Study: A Study of a Protease Inhibitor With Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With HIV-1.
Clinical trial NCT00326963 · COMPLETED
Trial details
- NCT number
- NCT00326963
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2006-03-01
- Primary completion
- 2007-04-01
- Enrollment
- 142
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.